Acomplia
Acomplia weight loss drug is an anorexic against obesity drugs. It is a cannabinoid receptor antagonist CB1. Acomplia Rimonabant has been found to stop the food enough to help people lose weight, and could also help reduce the urge other unhealthy as smoking.
This is not a weight loss control solution that in a study, people who have contributed to overload an average of 20 pounds, and was found to be very useful for patients who suffer from the ‘obesity.
Acomplia drug is one of the most recent, and in fact most of a new method for the control of body weight. Acomplia works to be an antagonist cannabinoid receptor. This means that Acomplia prevents the normal endogenous cannabinoid activity in the brain by stimulating the so-called CB1 receptors.
The clinical trials that have performed over the last few years are impressive and have shown that these receptor sites may be responsible for most of appetite, because the results also show that Acomplia helps people to stop smoking and cardiovascular improves also factors like cholesterol Scaling.
With specific regard to weight loss, human showed an average weight loss of 10% of body weight, most importantly that the weight has remained outside even up to two years later. Also important, it seems that the majority of the weight lost is indeed difficult to lose the area around the waist. The average figures from clinical studies indicate a loss of fat of 20 pounds (9 kg) and 3 inches (8 cm) in diameter off life.
Further clinical studies have been undertaken to help smokers kick the habit. Even here Acomplia has been successful, demonstrating that people who use Acomplia have double the chances of quitting smoking for good, and perhaps also important to help smokers not to have any weight when they quit smoking (as is often the case that smokers trying to stop replace cigarettes with food, etc.).
On top of that, Acomplia has also been shown to improve HDL (good cholesterol) and triglyceride levels, showing benefit for diabetes and heart disease.
